. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: Mater Sci Eng C Mater Biol Appl. 2015 Aug 1;57:232–239. doi: 10.1016/j.msec.2015.07.027

Table III.

Summary of PCL Reservoir Samples Analyzed

Pharmaceutical	Area (mm²)	Membrane Thickness (um)	Dk (mm²/hr)
Caffeine	208	15	1.7E-11
	208	14	1.0E-11
	208	13.4	4.9E-13
	188	8.5	3.8E-10
	188	5.2	3.2E-10
Diltiazem-HCl	157	12.3	2.6E-12
Diltiazem-HCl	157	12.3	1.5E-12
Ranitidine-HCl	188	18.8	3.9E-10
	188	16.4	2.4E-10
	188	14.7	1.2E-10
Verapamil-HCl	188	25.5	1.9E-11
Atenolol	188	6	1.5E-10
Famotidine	190	16.2	1.7E-11
	173	16.2	2.7E-10
	173	16.2	7.1E-11
Hydrocortisone	157	10.8	5.4E-11
Hydrocortisone	157	12.3	1.4E-10
Labetalol-HCl	208	14.5	2.5E-12
	208	11.8	2.6E-11
	208	11.8	1.9E-11